Vascular Cognitive Impairment and Dementia

Size: px
Start display at page:

Download "Vascular Cognitive Impairment and Dementia"

Transcription

1 Vascular Cognitive Impairment and Dementia January 24, 2009 Saving the Brain 3 rd Annual Conference Toronto, Ontario Demetrios J. Sahlas, MSc, MD, FRCPC MG DeGroote Professor in Stroke Management Associate Professor, Division of Neurology, McMaster University Central South Regional Stroke Centre, Hamilton Health Sciences

2 Objectives 1) To describe the different patterns of cognitive impairment that can emerge following a stroke. 2) To review the 2008 recommendations for for vascular cognitive impairment and dementia. 3) To consider management of vascular cognitive impairment and dementia.

3 2008 recommendations all patients with vascular risk factors and those with clinically evident stroke or TIA should be considered at high risk for vascular cognitive impairment broken into sections on Assessment, Timing, and Management

4 What is Meant by Cognitive Impairment? impairment in one or more cognitive domains: memory, language, visuospatial function, executive function, praxis may be mild, moderate, or severe referred to as dementia when affects daily social or occupational function

5 1. How common is cognitive impairment following a stroke? a) 10% b) 33% c) 64% d) 99%

6 After 3 Months... up to 64% of stroke patients have some degree of cognitive impairment severe enough to meet criteria for dementia in a third of patients risk of developing dementia in the future is also increased Hachinski et al. Stroke 2006;37:2220

7 2. Vascular Dementia is characterized by which of the following clinical characteristics? a) insidious onset b) stepwise decline c) response to cholinesterase inhibitors

8 How Does a Stroke Result in Cognitive Impairment? large-vessel territory infarcts rob patient of specific cognitive domains depending upon cortical region involved can lead to multi-infarct dementia small-vessel (lacunar) infarcts importance of thalamus in cognition can lead to strategic infarct dementia

9 Vascular Cognitive Disorders Multiple Infarct Dementia multiple cortical infarcts Strategic Infarct Dementia Subcortical Ischemic Vascular Dementia lacunar infarcts and white matter disease Mixed Alzheimer s Disease and Cerebrovascular Disease

10

11 Subcortical Ischemic Vascular Disease (SIVD) chronic atherosclerotic vessel pathology lipohyalinosis microatheromatosis small vessel (such as lenticulostriate) as well as microvascular damage

12 Subcortical Ischemic Vascular Disease (SIVD) vessel changes may result in subcortical ischemic white matter pathology microinfarcts rarefaction of myelin glial cell pathology

13 A D

14 Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain Selden, Gitelman, Salamon-Murayama, Parrish and Mesulam, Brain 1998;121:

15 The neuropsychological profile found in patients with subcortical ischemic vascular disease O'Sullivan et al. J Neurol Neurosurg Psychiatry 2004;75:441-7

16 What Pre-Existing Factors Predispose to Cognitive Impairment after a Stroke or TIA?

17 Effects of Normal Aging Alzheimer s or other neurodegenerative pathology Atherosclerosis (SIVD) and cerebral infarction

18 Braak & Braak stages of AD Stage 1 Transentorhinal Cortex Stage 2 Entorhinal Cortex Hippocampus Proper Stage 4 Nucleus Reuniens Posterior Cingulate Temporal Isocortex Stage 3 Nucleus Basalis of Meynert Hypothalamus Stage 5 Anterior Thalamus Isocortical Association Areas ORANGE = LIMBIC SYSTEM STRUCTURES Stage 6 Primary Motor & Sensory Areas Dentate Gyrus Substantia Nigra Striatum

19 The Nun Study prevalence of dementia with AD pathology present: stages 1-2: 22% stages 3-4: 43% stages 5-6: 70% 93% of nuns with dementia also had at least one subcortical stroke data from Snowden et al. JAMA 1997;277:

20 The Nun Study (con t) only 57% with AD pathology alone were demented 88% with both AD and CVD pathology were demented only 2.5% of those with dementia had only cerebrovascular lesions present data from Snowden et al. JAMA 1997;277:

21 2008 recommendations 6.3a Assessment: use of validated screening tools MoCA preferable to MMSE patients should also be screened for depression further cognitive or neuropsychological testing, as appropriate

22 Why Screen for Cognitive Impairment in Stroke Patients?

23

24 Case History 73 year-old man brief episode of tingling involving left hand hypertensive, obese, high cholesterol, smoker known to harbor bilateral carotid artery stenosis

25 Physical Exam & CT (head) alert, oriented, speech normal MMSE 27/30 neurological exam notable for sensory and visual extinction on the left CT scan (head) demonstrates hitherto unsuspected infarct involving the right parietal lobe

26

27 NINDS-CSN VCI 2006 Harmonization Standards screening questions established components of ideal as well as minimum dataset neuropsychological working group 60 min protocol (four domains) 30 and 5 min protocols

28 5-Minute Protocol Montreal Cognitive Assessment (MoCA) 5 word memory task (registration, recall, recognition) 6 item orientation 1 letter phonemic fluency MoCA available at

29 Further Evaluation supplemental testing rest ofmoca semantic fluency (animal naming) Trail Making Test MMSE (1 hour pre- or post-) MoCA available at

30 Trails A Trails B

31 2008 recommendations 6.3b Timing: those at high risk should be assessed periodically testing appropriate at various transition points, including upon admission or discharge to hospital, and periodically during outpatient follow-up

32 Roman et al. Neurology 1993;43:250 Hachinski et al. Arch Neurol 1975;32:632 Diagnostic Criteria for Vascular Dementia DSM IV (TR) NINDS-AIREN criteria Hachinski Ischemic Score

33 2008 recommendations 6.3c Management: aggressive vascular risk factor management referral to health care professional with specific expertise, as appropriate comprehensive team approach intervention strategies

34 Treatment with Cholinesterase Inhibitors galantamine (Reminyl ER) 8mg a day increase by 8mg to 24mg a day donepezil (Aricept) 5mg or 10mg a day rivastigmine (Exelon) 1.5 to 6mg bid also available as a patch Erkinjunti et al. Lancet 2002;359:1283 Black et al. Stroke 2003;34:2323

35 Summary cognitive impairment is exceedingly common after stroke up to two-thirds of patients subcortical ischemic vascular disease detracts from cognitive reserve and can also result in cognitive impairment executive dysfunction

36 Summary screening for cognitive impairment is now considered best practice in stroke patients there are standard tests for accomplishing this: 5 minute core protocol (12 pts) MoCA +/- MMSE (both up to 30 pts) supplemental tests

37 Summary treatment with medications, such as cholinesterase inhibitors, may be helpful, although evidence is not robust and one last word...

38

39 The Nun Study participants with lacunar infarcts had especially high prevalence of dementia compared to those without infarcts the odds ratio [OR] for dementia was 20.7 (95% CI= )

40 (CNN) -- Eleven million Americans will have strokes this year. But they won't know it. "There are 20 silent strokes occurring in this country each year for every single symptomatic stroke that's occurring," said Dr. Jeffrey Saver, a neurologist at the University of California-Los Angeles Stroke Center. "I think that a lot of physicians and patients and families are going to be surprised by the numbers. Previous studies had suggested that silent strokes were quite common, but research conducted by Saver and his colleagues (funded by the National Institutes of Health and the American Heart Association) put a concrete number on the incidence of silent stroke. He called the figure "shocking and dramatic."

Stroke & Alzheimer s Disease: An Inflammatory Duo

Stroke & Alzheimer s Disease: An Inflammatory Duo Stroke & Alzheimer s Disease: An Inflammatory Duo Stroke and Dementia One in 3 will experience a stroke, dementia or both 64% of persons with a stroke have some degree of cognitive impairment and up to

More information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate

More information

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment Dementia David Lam, MD, FRCPC, Psychiatry Assistant Clinical Professor Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton, Ontario Objectives Aging and Forgetfulness Define

More information

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013 Overview Neuropsychological Assessment in Stroke Brandon Ally, PhD Department of Neurology What is Neuropsychology Stroke Specific Neuropsychology Neuropsychological Domains Case Study What is Neuropsychology?

More information

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease 2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease Dylan Wint, M.D. ALZHEIMER DISEASE Dylan Wint, M.D. Lou Ruvo Center for Brain Health DEFINITIONS Cognitive related to thinking,

More information

CRITERIA FOR AD DEMENTIA June 11, 2010

CRITERIA FOR AD DEMENTIA June 11, 2010 CRITERIA F AD DEMENTIA June 11, 2010 Alzheimer s Disease Dementia Workgroup Guy McKhann, Johns Hopkins University (Chair) Bradley Hyman, Massachusetts General Hospital Clifford Jack, Mayo Clinic Rochester

More information

Copywrite - Eric Freitag, Psy.D., 2012

Copywrite - Eric Freitag, Psy.D., 2012 Diagnosis, Intervention and Care for Patients With Cognitive Impairment Eric J. Freitag, Psy.D, FACPN Diplomate, American College of Professional Neuropsychology Mt. Diablo Memory Center Founder/Executive

More information

Update on Treatment of the Dementias

Update on Treatment of the Dementias Update on Treatment of the Dementias Mark Pippenger, MD Behavioral Neurology Associate Clinical Professor of Neurology University of Arkansas for Medical Sciences Disclosures I will be discussing off-label

More information

Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi.

Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Suresh Kumar, M.D. AUTHOR Director of: Neurology & Headaches Center Inc. Neurocognitve &TBI Rehabilitation Center

More information

Vertebrobasilar Disease

Vertebrobasilar Disease The Vascular Surgery team at the University of Michigan is dedicated to providing exceptional treatments for in the U-M Cardiovascular Center (CVC), our new state-of-the-art clinical facility. Treatment

More information

In conjunction with clinical history, structural

In conjunction with clinical history, structural A QUICK GUIDE FOR NEUROIMAGING OF COMMON DEMENTIAS SEEN IN CLINICAL PRACTICE PRINT THIS ARTICLE David F. Tang-Wai, MDCM, FRCPC, assistant professor of neurology and geriatric medicine at the University

More information

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia

More information

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Community Geriatric Mental Health Model of Continuum of Cognition with Aging Normal Mild cognitive

More information

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College Bedside cognitive examination beyond the MMSE Dr Richard Perry Dept of Neurosciences Imperial College Overview Initial observations Cognitive rating scales Assessing cognitive domains Memory Language Visuospatial

More information

Staging and Treatment of Dementia

Staging and Treatment of Dementia Staging and Treatment of Dementia Ami Hall DO 10/25/14 1 Objectives What are the two most common types of dementias seen in a primary care office How are they staged What treatments are available Definition

More information

Memantine (Ebixa) Drug treatment for Alzheimer s disease

Memantine (Ebixa) Drug treatment for Alzheimer s disease IS 20 October 2011 Information sheet Memantine (Ebixa) Drug treatment for Alzheimer s disease Introduction... 1 How does Ebixa work?... 1 Who might benefit?... 2 What effect might Ebixa have?... 2 How

More information

Alzheimer s and Depression: What is the Connection?

Alzheimer s and Depression: What is the Connection? Alzheimer s and Depression: What is the Connection? Ladson Hinton MD Professor and Director of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Director, Education Core, Alzheimer

More information

Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas

Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas Billing and Coding in Neurology and Headache Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas CPT Codes vs. ICD Codes Category

More information

Dementia Causes and Neuropsychological Evaluation of the Older Adult

Dementia Causes and Neuropsychological Evaluation of the Older Adult Dementia Causes and Neuropsychological Evaluation of the Older Adult Laurie N. Culp, Ph.D. Pate and Culp Psychological Assoc. 2440 Lawrenceville Highway Suite 200 Decatur, GA 30033 678-595-0062 lculp@emory.edu

More information

ALBERTA PROVINCIAL STROKE STRATEGY (APSS)

ALBERTA PROVINCIAL STROKE STRATEGY (APSS) ALBERTA PROVINCIAL STROKE STRATEGY (APSS) Stroke Systems of Care Key Components APSS Pillar Recommendations March 28, 2007 1 The following is a summary of the key components and APSS Pillar recommendations

More information

How To Write Long Term Care Insurance

How To Write Long Term Care Insurance By Lori Boyce, AVP Risk Management and R&D Underwriting long term care insurance: a primer Every day Canadians die, are diagnosed with cancer, have heart attacks and become disabled and our insurance solutions

More information

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia By Scott Knight, Director, SLR Diagnostics & Assessments, a division of Sibley & Associates Inc., and Konstantine

More information

Targeted Screening for Dementia

Targeted Screening for Dementia Targeted Screening for Dementia Dementia may be the most important health problem for the baby-boomer generation and healthcare system. As new disease-modifying drugs become available in the next decade,

More information

Diagnosis and Initial Management of Cognitive Disorders

Diagnosis and Initial Management of Cognitive Disorders Diagnosis and Initial Management of Cognitive Disorders January 29, 2016 Kelly Garrett, PhD Cathleen Obray, MD, MHS Neurosciences Clinical Program Cognitive Care Team None Disclosures Neurosciences Clinical

More information

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have

More information

Objectives. Evaluation of Memory Loss. Cognitive Impairment. Clinical Questions. Medicare Wellness Visit

Objectives. Evaluation of Memory Loss. Cognitive Impairment. Clinical Questions. Medicare Wellness Visit Evaluation of Memory Loss and Mild Cognitive Impairment Skotti Church, MD Geriatrics Grand Rounds 4/3/2014 Objectives 1. Describe recommendations and tools for evaluation of cognitive impairment 2. Define

More information

DIAGNOSTIC CRITERIA OF STROKE

DIAGNOSTIC CRITERIA OF STROKE DIAGNOSTIC CRITERIA OF STROKE Diagnostic criteria are used to validate clinical diagnoses. Here below MONICA diagnostic criteria are reported. MONICA - MONItoring trends and determinants of CArdiovascular

More information

Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project

Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project Tohoku J. Exp. Med., 2008, 215, 125-131 MCI and Dementia in a Community 125 Review Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project KENICHI

More information

Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment

Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment Teresa Leung Therapist Prince of Wales Hospital 7 th May, 2012 Outline of Presentation Introduction Study Objectives,

More information

GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY BE AN EFFECTIVE TREATMENT FOR ALZHEIMER S DISEASE AND VASCULAR DEMENTIA

GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY BE AN EFFECTIVE TREATMENT FOR ALZHEIMER S DISEASE AND VASCULAR DEMENTIA CONTACT: Alzheimer s Association AAIC newsroom, 202-249-4002, media@alz.org Niles Frantz, Alzheimer s Association, 312-335-5777, niles.frantz@alz.org GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY

More information

Long Term Care Formulary HCD - 09. Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine)

Long Term Care Formulary HCD - 09. Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine) 1 of 8 USE OF CHOLINESTERASE (AChE) INHIBITORS The cholinesterase inhibitor anti-dementia drugs are indicated for the symptomatic treatment of patients with mild to moderate dementia of the Alzheimer s

More information

Dementia: Delivering the Diagnosis

Dementia: Delivering the Diagnosis Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology University of Utah Diagnosing Dementia

More information

Emergency Room Treatment of Psychosis

Emergency Room Treatment of Psychosis OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different

More information

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic

More information

Brain Structures That are Involved with Memory

Brain Structures That are Involved with Memory Early Theories of Brain Structures That are Involved with Psychology 372 Sensation Sensory Attention Rehearsal STM Storage Retrieval Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio

More information

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making

More information

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,

More information

Introduction to Neuropsychological Assessment

Introduction to Neuropsychological Assessment Definitions and Learning Objectives Introduction to Neuropsychological Assessment Alan Sunderland Reader in Clinical Neuropsychology Neuropsychological assessment seeks to define cognitive disability in

More information

Mild Cognitive Impairment, Dementia and Driving: Concluding remarks

Mild Cognitive Impairment, Dementia and Driving: Concluding remarks Mild Cognitive Impairment, Dementia and Driving: Concluding remarks Sokratis G. Papageorgiou, MD, PhD Behavioral Neurology & Neuropsychology Unit, Department of Neurology, University General Hospital ATTIKON,

More information

Vascular Dementia. Information sheet

Vascular Dementia. Information sheet IS 21 October 2002 Information sheet Vascular Dementia Introduction... 1 What is vascular dementia?... 1 Causes of vascular dementia... 2 Transient ischaemic attacks (TIAs)... 3 Strokes... 3 Symptoms and

More information

The Montreal Cognitive Assessment (MoCA): Concept and Clinical Review

The Montreal Cognitive Assessment (MoCA): Concept and Clinical Review Julayanont, P., Phillips, N., Chertkow, H., and Nasreddine, Z.S.. To appear in A.J. Larner (Ed.), Cognitive Screening Instruments: A Practical Approach. Springer-Verlag, pp. 111-152. 1. Introduction The

More information

MEDIAL TEMPORAL LOBE (THE LIMBIC SYSTEM)

MEDIAL TEMPORAL LOBE (THE LIMBIC SYSTEM) MEDIAL TEMPORAL LOBE (THE LIMBIC SYSTEM) On the medial surface of the temporal lobe are three structures critical for normal human functioning. From rostral to caudal, they are the olfactory cortex, the

More information

Costs of Medical Care for Dementia Patients in Taiwan: A Population-Based Study

Costs of Medical Care for Dementia Patients in Taiwan: A Population-Based Study Costs of Medical Care for Dementia Patients in Taiwan: A Population-Based Study L.-J. E. Ku 1, T.-H. Lu 1, S.-L. Wu 1, M.-C. Pai 2* 古 鯉 榕, 呂 宗 學, 吳 士 良, 白 明 奇 April 19, 2013 1 Institute of Public Health,

More information

Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease

Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease IS 11 October 2011 Information sheet Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease Introduction... 1 How does Aricept work?... 1 Who might benefit from Aricept?... 2 What effect

More information

Social Security Disability Insurance and young onset dementia: A guide for employers and employees

Social Security Disability Insurance and young onset dementia: A guide for employers and employees Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll

More information

APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION

APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION ICD-9-CM codes for cerebrovascular diseases is not user friendly. This presentation is designed to assist

More information

THEORIES OF NEUROLOGICAL AGING AND DEMENTIA

THEORIES OF NEUROLOGICAL AGING AND DEMENTIA THEORIES OF NEUROLOGICAL AGING AND DEMENTIA Aging Overview The primary care physician must advise middle-age and older patients about ways to age successfully. Dementia is a common disabling illness that

More information

Frequently Asked Questions

Frequently Asked Questions Frequently Asked Questions Business Office: 598 Airport Boulevard Suite 1400 Morrisville NC 27560 Contact: support@cognitrax.com Phone: 888.750.6941 Fax: 888.650.6795 www.cognitrax.com Diseases of the

More information

EMR Decision Support Tools for Alzheimer s and Related Dementias

EMR Decision Support Tools for Alzheimer s and Related Dementias EMR Decision Support Tools for Alzheimer s and Related Dementias 1. Screening Tool Criteria For When to Use: As a general cognitive screening tool or as part of an annual exam (Medicare Annual Wellness

More information

Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento Precoce: la Collaborazione MMG-Specialista

Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento Precoce: la Collaborazione MMG-Specialista 55 Congresso Nazionale SIG Firenze Auditorium Palazzo dei Congressi 2 Dicembre 2010 Invecchiamento e Longevità: più Geni o più Ambiente Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento

More information

Cognitive impairment (CI) in Multiple Sclerosis

Cognitive impairment (CI) in Multiple Sclerosis Multiple Sclerosis and Mild Cognitive Impairment What are the cognitive impairments in MS and why are the terms dementia and Mild Cognitive Impairment (MCI) rarely used? By Ronald Devere, MD Cognitive

More information

Galantamine hydrobromide (Reminyl) Drug treatment for Alzheimer s disease

Galantamine hydrobromide (Reminyl) Drug treatment for Alzheimer s disease IS 17 October 2011 Information sheet Galantamine hydrobromide (Reminyl) Drug treatment for Alzheimer s disease Introduction... 1 How does Reminyl work?... 1 Who might benefit?... 2 What effect might Reminyl

More information

What do these stories illustrate about ER/ALC issue?

What do these stories illustrate about ER/ALC issue? What do these stories illustrate about ER/ALC issue? Maximizing the Impact of Rehab on Provincial Priority Issues Mark Bayley, MD, FRCPC Medical Director, Neuro Rehabilitation Program, Toronto Rehab and

More information

Linguistic Ability in Early Life and the Neuropathology of Alzheimer s Disease and Cerebrovascular Disease

Linguistic Ability in Early Life and the Neuropathology of Alzheimer s Disease and Cerebrovascular Disease Linguistic Ability in Early Life and the Neuropathology of Alzheimer s Disease and Cerebrovascular Disease Findings from the Nun Study D.A. SNOWDON, a,b L.H. GREINER, a AND W.R. MARKESBERY a,c a Sanders-Brown

More information

Memory Loss: It s Not Always Alzheimers. Andrew Massey, M.D. Department of Internal Medicine University of Kansas School of Medicine--Wichita

Memory Loss: It s Not Always Alzheimers. Andrew Massey, M.D. Department of Internal Medicine University of Kansas School of Medicine--Wichita Memory Loss: It s Not Always Alzheimers Andrew Massey, M.D. Department of Internal Medicine University of Kansas School of Medicine--Wichita Hendrikjje van Andel Schipperr Age 115 Don t smoke and don t

More information

Dementia One Day Essentials 2015

Dementia One Day Essentials 2015 Dementia One Day Essentials 2015 1 Dementia One Day Essentials 2015 2 At Risk of Dementia: Mild Cognitive Impairment and Other Non-Dementia Diagnoses Dr Jill Rasmussen Declaration of Interests NHS: GP

More information

NEUROANATOMY 6 Limbic System

NEUROANATOMY 6 Limbic System NEUROANATOMY 6 Limbic System The Limbic System The part of the brain involved with learning, memory and emotion. It is affected in many neuropsychiatric diseases including schizophrenia, Alzheimer s disease

More information

09/05/2014. Painting pictures of the brain with numbers. Overview

09/05/2014. Painting pictures of the brain with numbers. Overview Painting pictures of the brain with numbers Neurology for Insurers Dr Ian Cox & Adele Groyer (Gen Re) Overview Critical Illness Product Background Why should we be interested in neurology? Consult our

More information

Everyone has mild memory lapses from time to time. You go

Everyone has mild memory lapses from time to time. You go Coping With Memory Loss Everyone has mild memory lapses from time to time. You go from the kitchen to the bedroom to get something, only to find yourself wondering what you needed. You can t find your

More information

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease Outline of Today s Lecture Why is Alzheimer s disease a problem? What is Alzheimer s Disease? What causes Alzheimer s disease? How can

More information

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles.

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles. Unit 13: Dementia Awareness Unit code: DEM 201 Unit reference number: J/601/2874 QCF level: 2 Credit value: 2 Guided learning hours: 17 Unit summary The aim of the unit is to enable learners to gain knowledge

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Neuropsychological Testing

Neuropsychological Testing Last Review Date: March 17, 2015 Number: MG.MM.ME.18dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Cognitive Assessment and Mini Mental Status Exam for Nurses. Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District

Cognitive Assessment and Mini Mental Status Exam for Nurses. Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District Cognitive Assessment and Mini Mental Status Exam for Nurses Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District Objectives An understanding of what makes up a cognitive

More information

Virtual Reality Technology in Stroke Rehabilitation: Ready for Prime Time

Virtual Reality Technology in Stroke Rehabilitation: Ready for Prime Time Virtual Reality Technology in Stroke Rehabilitation: Ready for Prime Time Hillel Finestone, MD CM, FRCPC (Physiatrist/PM&R) Ontario Hospital Association Third Annual Senior Friendly Hospital Care Conference

More information

Normal Aging versus Alzheimer Disease Drugs to treat the symptoms that are not due to old age. Leah Wright, HBSc. BSP student June 2006

Normal Aging versus Alzheimer Disease Drugs to treat the symptoms that are not due to old age. Leah Wright, HBSc. BSP student June 2006 Normal Aging versus Alzheimer Disease Drugs to treat the symptoms that are not due to old age. Leah Wright, HBSc. BSP student June 2006 Alzheimer Disease is a form of dementia that affects 5% of men and

More information

ISSUED BY: TITLE: ISSUED BY: TITLE: President

ISSUED BY: TITLE: ISSUED BY: TITLE: President CLINICAL PRACTICE GUIDELINE PROFESSIONAL PRACTICE TITLE: Stroke Care Rehabilitation Unit DATE OF ISSUE: 2005, 05 PAGE 1 OF 7 NUMBER: CPG 20-3 SUPERCEDES: New ISSUED BY: TITLE: Chief of Medical Staff ISSUED

More information

Psychological and Neuropsychological Testing

Psychological and Neuropsychological Testing Psychological and Neuropsychological Testing I. Policy University Health Alliance (UHA) will reimburse for Psychological and Neuropsychological Testing (PT/NPT) when it is determined to be medically necessary

More information

Cardiac Rehabilitation: Strategies Approaching 2020

Cardiac Rehabilitation: Strategies Approaching 2020 ACC Banff 2015 Cardiac Rehabilitation: Strategies Approaching 2020 James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Libin Cardiovascular

More information

Using Objective Measures to Facilitate Rehabilitation Referral

Using Objective Measures to Facilitate Rehabilitation Referral Using Objective Measures to Facilitate Rehabilitation Referral Mark Bayley MD, FRCPC Medical Director, Neuro Rehabilitation Program, Toronto Rehabilitation Institute Associate Professor, Division of Physiatry,

More information

Unmet Needs for Parkinson s Disease Therapeutics

Unmet Needs for Parkinson s Disease Therapeutics Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical

More information

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA Disclosures Jeanie Luciano Genentech speakers bureau Claranne Mathiesen - none 1 Objective

More information

Prescribing Framework for Donepezil in the Treatment and Management of Dementia

Prescribing Framework for Donepezil in the Treatment and Management of Dementia Hull & East Riding Prescribing Committee Prescribing Framework for Donepezil in the Treatment and Management of Dementia Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker) GP

More information

DRIVER REHABILITATION OVERVIEW

DRIVER REHABILITATION OVERVIEW DRIVER REHABILITATION OVERVIEW What is included in a Driving Evaluation? The purpose of the evaluation is to determine if the individual s medical condition, medications, functional limitations and/ or

More information

THOMAS D. PARSONS Department of Neurology, School of Medicine University of North Carolina at Chapel Hill Chapel Hill, North Carolina, USA.

THOMAS D. PARSONS Department of Neurology, School of Medicine University of North Carolina at Chapel Hill Chapel Hill, North Carolina, USA. Intern. J. Neuroscience, 116:1271 1293,2006 Copyright C 2006 Informa Healthcare ISSN: 0020-7454 / 1543-5245 online DOI: 10.1080/00207450600920928 NEUROCOGNITIVE DIFFERENTIAL DIAGNOSIS OF DEMENTING DISEASES:

More information

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late

More information

Alzheimer's: The Latest Assessment and Treatment Strategies

Alzheimer's: The Latest Assessment and Treatment Strategies Questions from chapter 1 Alzheimer's: The Latest Assessment and Treatment Strategies 1) What is a loss of cognitive and intellectual powers without changes in consciousness. a) dementia b) delusions c)

More information

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI)

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Mike R. Schoenberg, PhD, ABPP-CN Diplomate, American Board of Clinical Neuropsychology Licensed Psychologist Departments of Psychiatry

More information

Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies

Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies Michael A. Ross MD FACEP Associate Professor of Emergency Medicine Wayne State University School of Medicine Detroit

More information

Occupational Therapy in Cognitive Rehabilitation

Occupational Therapy in Cognitive Rehabilitation Occupational Therapy in Cognitive Rehabilitation Connie MS Lee Occupational therapist Queen Mary Hospital Hong Kong Cognition Cognition refers to mental processes that include the abilities to concentrate,

More information

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual

More information

TORONTO STROKE FLOW INITIATIVE - Inpatient Rehabilitation Best Practice Recommendations Guide (updated January 23, 2014)

TORONTO STROKE FLOW INITIATIVE - Inpatient Rehabilitation Best Practice Recommendations Guide (updated January 23, 2014) TORONTO STROKE FLOW INITIATIVE - Inpatient Rehabilitation Best Practice Guide (updated January 23, 2014) Objective: To enhance system-wide performance and outcomes for persons with stroke in Toronto. Goals:

More information

The Normal Neurological Examination

The Normal Neurological Examination Normal Neurological Examination 1 of 10 The Normal Neurological Examination Introduction One of the most daunting aspects of the medical examination for the Emergency Physician and the primary care provider

More information

75-09.1-08-02. Program criteria. A social detoxi cation program must provide:

75-09.1-08-02. Program criteria. A social detoxi cation program must provide: CHAPTER 75-09.1-08 SOCIAL DETOXIFICATION ASAM LEVEL III.2-D Section 75-09.1-08-01 De nitions 75-09.1-08-02 Program Criteria 75-09.1-08-03 Provider Criteria 75-09.1-08-04 Admission and Continued Stay Criteria

More information

DSM IV Criteria for Dementia

DSM IV Criteria for Dementia Dementia Differential Diagnosis and Management in the Age of Biomarkers November, 9, 2012 38 th Annual Kaiser Permanente Neurology Symposium Helena Chui, MD Department of Neurology University of Southern

More information

Appendix L: HQO Year 1 Implementation Priorities

Appendix L: HQO Year 1 Implementation Priorities Appendix L: HQO Year 1 Implementation Priorities Chronic Obstructive Pulmonary Disease (Source: COPD Chairs) Non-Invasive Positive Pressure Ventilation Early Ambulation If possible, seek patient preferences

More information

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre GP workshop Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre Stroke: the Facts Stroke: the Facts Every 5 minutes someone in the UK has a stroke 1 in 4 men and 1 in 5 women will have a stroke

More information

Atherosclerosis of the aorta. Artur Evangelista

Atherosclerosis of the aorta. Artur Evangelista Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis

More information

Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease

Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease Understanding NICE guidance Information for people who use NHS services Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease NICE technology appraisal guidance advises on when and

More information

MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: 8.01.19 CATEGORY: Therapy/Rehabilitation

MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: 8.01.19 CATEGORY: Therapy/Rehabilitation MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical

More information

Chapter 7: The Nervous System

Chapter 7: The Nervous System Chapter 7: The Nervous System I. Organization of the Nervous System Objectives: List the general functions of the nervous system Explain the structural and functional classifications of the nervous system

More information

Collaborative Care for Alzheimer s Disease

Collaborative Care for Alzheimer s Disease The Health Care Workforce for Older Americans: Promoting Team Care Institute of Medicine Symposium October 2008 Collaborative Care for Alzheimer s Disease Christopher M. Callahan, MD Cornelius and Yvonne

More information

THE FUTURE OF STROKE REHABILITATION

THE FUTURE OF STROKE REHABILITATION Disclosure of Financial Relationships Gary M. Abrams M.D. THE FUTURE OF STROKE REHABILITATION Gary M. Abrams M.D. Professor of Clinical Neurology Director of Neurorehabilitation UCSF Has disclosed the

More information

The diagnosis of dementia for people living in care homes. Frequently Asked Questions by GPs

The diagnosis of dementia for people living in care homes. Frequently Asked Questions by GPs The diagnosis of dementia for people living in care homes Frequently Asked Questions by GPs A discussion document jointly prepared by Maggie Keeble, GP with special interest in palliative care and older

More information

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium October 30, 2008 Barry Libman, RHIA, CCS, CCS-P President, Barry Libman Inc. Stroke Coding Issues Outline Medical record documentation

More information

REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD

REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD What is Rehabilitation Medicine? Rehabilitation Medicine (RM) is the medical specialty with rehabilitation as its primary strategy. It provides services

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

Stroke Care First week

Stroke Care First week Stroke Care First week Florence Nightingale (1820 1910) Stroke Unit Dedicated personnel trained in stroke management Stepwise guidelines supported by explicit checklists Continuous monitoring available

More information

Monday, August 25, 2014

Monday, August 25, 2014 Danish Dementia Research Centre, Copenhagen University Kristian Steen Frederiksen, MD, PhD; Danish Dementia Research Centre, Copenhagen University Danish Dementia Research Centre, Copenhagen University

More information

Behavioral Health Psychological/Neuropsychological Testing Guidelines

Behavioral Health Psychological/Neuropsychological Testing Guidelines Behavioral Health Psychological/Neuropsychological Testing Guidelines Psychological testing (procedural code 96101) and Neuropsychological Testing (procedural code 96118) involve the culturally and linguistically

More information